A

Arbutus Biopharma Corp

ABUS

3.80500
USD
0.035
(0.93%)
مفتوح الان
حجم التداول
13,485
الربح لكل سهم
0
العائد الربحي
0
P/E
-9
حجم السوق
747,576,835
أصول ذات صلة
B
BNTX
-5.530
(-6.42%)
80.570 USD
C
CRSP
-2.450
(-4.28%)
54.840 USD
E
EDIT
-0.28500
(-5.26%)
5.13500 USD
MRNA
-25.020
(-20.99%)
94.160 USD
N
NVAX
-0.250
(-1.95%)
12.560 USD
REGN
13.14
(1.22%)
1,091.19 USD
R
RGLS
-0.09000
(-5.06%)
1.69000 USD
S
SRPT
1.650
(1.16%)
144.000 USD
V
VYGR
-0.59000
(-6.37%)
8.67000 USD
الأخبار المقالات

العنوان: Arbutus Biopharma Corp

القطاع: Healthcare
الصناعة: Biotechnology
Arbutus Biopharma Corp is a biopharmaceutical company. The company discovers, develops, and commercializes cures for patients suffering from Hepatitis B infection. The company is focused on developing a portfolio of drug candidates with multiple mechanisms of action and is also involved in licensing Lipid nanoparticle technology.